Formamide → HCID 136395588, compound
Reaction equation
[NH2:1][C:2]1[N:6]([C:7]2[CH:8]=[C:9]([CH:16]=[CH:17][C:18]=2[CH3:19])[C:10]([NH:12][CH:13]2[CH2:15][CH2:14]2)=[O:11])[CH:5]=[N:4][C:3]=1[C:20](=O)[C:21]1[CH:26]=[CH:25][C:24]([SH:27])=[CH:23][CH:22]=1.[CH:29]([NH2:31])=O>CCOC(C)=O.O>[CH:13]1([NH:12][C:10](=[O:11])[C:9]2[CH:16]=[CH:17][C:18]([CH3:19])=[C:7]([N:6]3[CH:5]=[N:4][C:3]4[C:2]3=[N:1][CH:29]=[N:31][C:20]=4[C:21]3[CH:26]=[CH:25][C:24]([SH:27])=[CH:23][CH:22]=3)[CH:8]=2)[CH2:15][CH2:14]1Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Conditions
- Temperature
- 180 °C
Procedure
The mixture of 3-[5-Amino-4-(4-mercapto-benzoyl)-imidazol-1-yl]-N-cyclopropyl-4-methyl-benzamide (33 mg, 0.09 mmol), formamide (0.5 mL, excess), and p-tolunesolfonic acid (10 mg) was heated in the microwave at 180° C. for 30 min. After cooling, the mixture was diluted with EtOAc and water, and the EtOAc layer was separated, dried over Na2SO4, filtered and concentrated. The crude product was purified by preparatory HPLC to provide the title compound (20 mg, 59%) as a white solid: HPLC tR=2.47 min; MS m/z 416.27 [M+H]+.
Workup
- temperatureAfter cooling
- customthe EtOAc layer was separated
- dry with materialdried over Na2SO4
- filtrationfiltered
- concentrationconcentrated
- customThe crude product was purified by preparatory HPLC
Sources & evidence
- ORD record
- ord-7a17fc032df544de916cd1038241dba0
- Source dataset
- uspto-grants-2009_08
- Patent number
- US07569571B2
Reaction notes
Loading…